Tenaya Therapeutics, Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Tenaya Therapeutics, Inc. (TNYA) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$61.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-23.
Discontinued › Income Statement
us-gaap:GainLossOnDispositionOfAssets · last filed 2022-03-23
- Tenaya Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2021-12-31 was -$57.00K, a 2950.00% decline year-over-year.
- Tenaya Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2020-12-31 was $2.00K.
- Tenaya Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2020-09-30 was $0.00.
- Tenaya Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2021 was -$61.00K.
- Tenaya Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2020 was -$33.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$61.00K 10-K · filed 2022-03-23 | ||
| 2021-09-30 | -$4.00K 10-Q · filed 2021-11-10 | |||
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $2.00K derived: sum of 2 quarters · filed 2022-03-23 | -$33.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$35.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$35.00K 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |